🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Time of Oxytocin Initiation at 2nd Stage of Labor and Adverse Outcomes

RecruitingNAAges 18 Years - anyFemaleRambam Health Care Campus
NCT06181396 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Early oxytocin administration at the 2nd stage of labor is associated with a higher rate of vaginal delivery, shorter second stage duration, and fewer adverse maternal and neonatal outcomes.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Singleton pregnancy 2. Maternal age ≥ 18 years' old 3. Oxytocin administration initiated or renewed during second stage of labor Exclusion Criteria: 1. Maternal age \< 18 years' old 2. Multiple gestation pregnancy 3. Known fetal malformations 4. Uterine scar
💊

What it tests

  • Oxytocin
📍

Where

1 site
Rambam medical health campus
Haifa, Israel
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy